|Bid||0.00 x 3100|
|Ask||0.00 x 1000|
|Day's range||51.25 - 53.89|
|52-week range||33.36 - 55.70|
|Beta (5Y monthly)||0.62|
|PE ratio (TTM)||14.70|
|Earnings date||31 Jan 2022 - 04 Feb 2022|
|Forward dividend & yield||1.56 (2.87%)|
|Ex-dividend date||04 Nov 2021|
|1y target est||N/A|
Bright Path CEO Tony Quinone joins Yahoo Finance to discuss how the Build Back Better Plan will promote locally produced paharmaceutical drugs.
Yahoo Finance's Anjalee Khemlani discusses new COVID-19 protocols for NYC including mandates of vaccines for children ages 5-11 when indoors in restaurants or other public places.
Yahoo Finance's Editor-in-Chief Andy Serwer explains who is paying for all those millions of COVID-19 vaccines and where the money comes from.